The SARS-CoV-2 Beta variant evades Fc effector function by ancestral strain, study says
A new study published on the preprint server medRxiv* finds improved Fc cross-reactivity against certain severe acute respiratory syndrome coronavirus
Read moreA new study published on the preprint server medRxiv* finds improved Fc cross-reactivity against certain severe acute respiratory syndrome coronavirus
Read moreA synthetic antibody treatment developed by Regeneron reduced the risk of developing symptomatic COVID by more than 80 percent up
Read moreA study conducted by a consortium of Brazilian researchers has demonstrated that a hyperimmune serum consisting of purified antibody fragments
Read moreA treatment combining two antibodies (casirivimab and imdevimab) is recommended for two specific groups of patients with covid-19 by a
Read moreNew research from the University of Virginia School of Medicine quantifies the antibody response generated by the Pfizer and Moderna
Read moreA recent study conducted at the Medical University of Graz, Austria, has revealed that the number of naïve B cells
Read moreFindings from a study conducted in the UK support the country’s decision to extend the dosing interval of coronavirus disease
Read moreEngland has achieved relatively high vaccine coverage with at least one dose of vaccine having been given to three out
Read moreResearchers in the United States have shown that targeting the N-terminal domain (NTD) of the severe acute respiratory syndrome coronavirus
Read moreDeveloping a viable vaccine against dengue virus has proved difficult because the pathogen is actually four different virus types, or
Read more